5 (344) · € 21.99 · En Stock
Les resultats insuffisants de la radiochimiotherapie conventionnelle dans les cancers bronchiques non a petites cellules (CBNPC) ont motive l’evaluation d’une nouvelle strategie de modulation pharmacologique de la radiosensibilite tumorale basee sur
IJMS, Free Full-Text
Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation
Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
PDF) Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
IJMS, Free Full-Text
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
Full article: Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
Frontiers Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
IJMS, Free Full-Text
Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy